Video

Brisk walking may decrease TKR risk in OA


 

REPORTING FROM THE ACR ANNUAL MEETING

Encouraging patients with knee osteoarthritis to engage in brisk walking for at least 5 minutes per day pays big dividends in terms of reduced risk of total knee replacement, according to a new analysis of data from the National Institutes of Health-sponsored Osteoarthritis Initiative.

Vidyard Video

Whether walking increases or decreases the risk of structural deterioration and total knee replacement (TKR) in patients with knee osteoarthritis has been a controversial topic marked by conflicting data. That’s probably because prior studies haven’t taken into account walking intensity, Hiral Master said at the annual meeting of the American College of Rheumatology.

Ms. Master, a PhD candidate in physical therapy at the University of Delaware, Newark, presented a study of 1,854 patients with knee osteoarthritis who participated in the Osteoarthritis Initiative, all of whom had worn an accelerometer. This permitted calculation of time spent walking at various intensities. Subjects spent an average of 459 minutes per day not walking and 8 minutes walking at moderate to vigorous intensity, defined as a cadence of more than 100 steps per minute.

During 5 years of follow-up, the incidence of TKR was 6%. In this video interview, Ms. Master explains that patients who replaced 5 minutes of not walking with 5 minutes of brisk walking daily had an adjusted 14% reduction in the risk of TKR. A dose-response was evident, with more minutes of moderate to vigorous walking being associated with progressively larger reductions in the risk of this major surgery. Walking at a cadence of less than 100 steps per minute, regardless of duration, was nonprotective.

SOURCE: Master H et al. Arthritis Rheumatol. 2018;70(Suppl 10), Abstract 1166.

Recommended Reading

Severe OA sparks depression, surgery “ameliorates” depression in RA
MDedge Rheumatology
Nerve growth factor inhibitor shows phase 3 efficacy in osteoarthritis
MDedge Rheumatology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Rheumatology
Diclofenac’s cardiovascular risk confirmed in novel Nordic study
MDedge Rheumatology
Updates to EULAR hand OA management recommendations reflect current evidence
MDedge Rheumatology
Arthritis prevalent in older adults with any degree of depression
MDedge Rheumatology
Opioid use in OA may mean more activity-limiting pain
MDedge Rheumatology
Anxiety and depression widespread among arthritis patients
MDedge Rheumatology
Long-term follow-up results of ongoing trials highlighted at ACR 2018
MDedge Rheumatology
Risk score validated for major NSAID adverse events
MDedge Rheumatology